Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Pharm Pharmacol ; 62(12): 1740-5, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21054400

RESUMEN

OBJECTIVES: Amlodipine, a calcium channel blocker (CCB), is one of the most common antihypertensive medicines in Japan. We evaluated whether the calcium channel blocker confers cardiac protection through the renin-angiotensin-aldosterone system in male stroke-prone spontaneously hypertensive rats (SHR-SP). METHODS: Fifteen week-old rats were divided into 2 groups: amlodipine group (3 mg/kg/day, n = 5) and control group (n = 5). KEY FINDINGS: The CCB lowered systolic blood pressure significantly (P < 0.05). Plasma aldosterone concentration in the amlodipine group was remarkably lower than in the control group (P < 0.05), but plasma renin activity and plasma angiotensin II concentration were not different between the two groups. The CCB also suppressed the mRNA expression of brain natriuretic peptide, transforming growth factor-ß1, and fibronectin extracted from the left ventricle. CONCLUSIONS: These results suggest that amlodipine attenuates cardiac damage by lowering plasma aldosterone concentration in hypertensive rats with developing arteriosclerosis.


Asunto(s)
Amlodipino/farmacología , Antihipertensivos/farmacología , Cardiotónicos/farmacología , Fibronectinas/genética , Corazón/efectos de los fármacos , Hipertensión/tratamiento farmacológico , Miocardio/metabolismo , Péptido Natriurético Encefálico/genética , Factor de Crecimiento Transformador beta/genética , Aldosterona/sangre , Angiotensina II/sangre , Animales , Antihipertensivos/metabolismo , Presión Sanguínea/efectos de los fármacos , Bloqueadores de los Canales de Calcio/farmacología , Fibronectinas/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Corazón/fisiopatología , Hipertensión/genética , Hipertensión/fisiopatología , Masculino , Péptido Natriurético Encefálico/metabolismo , Ratas , Ratas Endogámicas SHR , Renina/sangre , Sistema Renina-Angiotensina/efectos de los fármacos , Factor de Crecimiento Transformador beta/metabolismo
2.
Clin Exp Hypertens ; 27(1): 9-15, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15773226

RESUMEN

Oxidative stress has been proposed as important in the pathogenesis of hypertension. Measurement of 8-iso prostaglandin F2alpha (8-ISO) is introduced for evaluating oxidative stress in vivo. 8-ISO is the major urinary metabolite of F2-isoprostanes and is formed nonenzymatically from the attack of superoxide radicals on arachidonic acid. We examined the oxidative stress level in the Dahl salt-sensitive (Dahl-S) rats and the Dahl salt-resistant (Dahl-R) rats. Dahl-S and Dahl-R rats were fed either a high salt diet (8% NaCl; HS) or low salt diet (0.3% NaCl; LS) for 3 weeks, and systolic blood pressure (SBP) and 24-hr urinary excretion of 8-ISO (U-8-ISO) were measured. In Dahl-S rats, the high salt diet induced hypertension (139 +/- 3 mmHg in LS versus 186 +/- 2 mmHg in HS, p < .05) and significantly increased the U-8-ISO (24.9 +/- 3.6 ng/24 hr in LS versus 63.2 +/- 14.6 ng/24 hr in HS, p < .05). No significant difference in blood pressure or U-8-ISO was observed between high-salt and low-salt treated Dahl-R rats. U-8-ISO concentration was correlated with SBP in all four experimental groups (r = 0.866). Moreover, urinary 8-hydroxy-2'-deoxyguanosine (U-8-OHdG), which is one of the most commonly used markers for evaluation of oxidative stress, was higher in Dahl-S-8% rats than in Dahl-S-0.3% rats (136.1 +/- 48.4 ng/24 hr in LS versus 322.8 +/- 46.7 ng/24 hr in HS, p < .05), and U-8-OHdG was correlated with SBP (r = 0.681) in Dahl-S rats. These results suggest oxygen radicals are involved in the pathogenesis of hypertension.


Asunto(s)
Desoxiguanosina/análogos & derivados , Dinoprost/análogos & derivados , Hipertensión/metabolismo , Estrés Oxidativo/fisiología , 8-Hidroxi-2'-Desoxicoguanosina , Animales , Biomarcadores , Presión Sanguínea , Peso Corporal , Desoxiguanosina/orina , Dinoprost/orina , Frecuencia Cardíaca , Masculino , Ratas , Ratas Endogámicas Dahl
3.
J Cardiovasc Pharmacol ; 44(6): 672-5, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15550786

RESUMEN

Dihydropyridine calcium channel blockers are not uniform in terms of their action on calcium channel. L-type calcium channel blockers dilate the resistance arterioles. Cilnidipine is a dihydropyridine calcium channel blocker that also acts on N-type calcium channels, and may dilate venules through its effect on the sympathetic receptor. The influence of an L-type calcium channel blocker (nifedipine) or this L+N type blocker at 10(-7) mol to 10(-4) mol on venular diameter was examined by superfusion of male Syrian hamster cheek pouches. Nifedipine dose dependently dilated the arterioles alone, whereas cilnidipine dilated both arterioles and venules. Application of 10(-7) mol omega conotoxin, an inhibitor of N-type channels, after nifedipine led to significant dilation of venules, while it had no influence when administered after cilnidipine. These findings indicate that the effects of calcium channel blockers on the venules differ according to the action on N-type calcium channels, and that cilnidipine (an L+N type calcium channel blocker) dilates venules through its additional action on N-type channels.


Asunto(s)
Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio Tipo L/efectos de los fármacos , Canales de Calcio Tipo N/efectos de los fármacos , Mucosa Bucal/irrigación sanguínea , Animales , Arteriolas/efectos de los fármacos , Cricetinae , Dihidropiridinas/farmacología , Masculino , Mesocricetus , Mucosa Bucal/efectos de los fármacos , Nifedipino/farmacología , Flujo Sanguíneo Regional/efectos de los fármacos , Vénulas/efectos de los fármacos , omega-Conotoxinas/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...